243 related articles for article (PubMed ID: 12651942)
1. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a).
Gordon MS; Kanegai CM; Doerr JR; Wall R
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4126-31. PubMed ID: 12651942
[TBL] [Abstract][Full Text] [Related]
2. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
[TBL] [Abstract][Full Text] [Related]
3. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia.
Thompson AA; Talley JA; Do HN; Kagan HL; Kunkel L; Berenson J; Cooper MD; Saxon A; Wall R
Blood; 1997 Aug; 90(4):1387-94. PubMed ID: 9269755
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia.
Astsaturov IA; Matutes E; Morilla R; Seon BK; Mason DY; Farahat N; Catovsky D
Leukemia; 1996 May; 10(5):769-73. PubMed ID: 8656670
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells.
Hashimoto S; Chiorazzi N; Gregersen PK
Mol Immunol; 1995 Jun; 32(9):651-9. PubMed ID: 7643857
[TBL] [Abstract][Full Text] [Related]
6. Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters.
Malone CS; Wall R
J Immunol; 2002 Apr; 168(7):3369-75. PubMed ID: 11907094
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the B-cell receptor B29 (CD79b) gene in familial chronic lymphocytic leukemia.
Payelle-Brogard B; Magnac C; Mauro FR; Mandelli F; Dighiero G
Blood; 1999 Nov; 94(10):3516-22. PubMed ID: 10552962
[TBL] [Abstract][Full Text] [Related]
8. Modifications of Igalpha and Igbeta expression as a function of B lineage differentiation.
Benlagha K; Guglielmi P; Cooper MD; Lassoued K
J Biol Chem; 1999 Jul; 274(27):19389-96. PubMed ID: 10383452
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the individual contributions of Igalpha (CD79a)- and Igbeta (CD79b)-mediated tonic signaling for bone marrow B cell development and peripheral B cell maturation.
Fuentes-Pananá EM; Bannish G; Karnell FG; Treml JF; Monroe JG
J Immunol; 2006 Dec; 177(11):7913-22. PubMed ID: 17114463
[TBL] [Abstract][Full Text] [Related]
10. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci.
Pasqualucci L; Migliazza A; Fracchiolla N; William C; Neri A; Baldini L; Chaganti RS; Klein U; Küppers R; Rajewsky K; Dalla-Favera R
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11816-21. PubMed ID: 9751748
[TBL] [Abstract][Full Text] [Related]
11. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines.
Verschuren MC; Comans-Bitter WM; Kapteijn CA; Mason DY; Brouns GS; Borst J; Drexler HG; van Dongen JJ
Leukemia; 1993 Dec; 7(12):1939-47. PubMed ID: 8255092
[TBL] [Abstract][Full Text] [Related]
12. The promoter and 5' flanking sequences controlling human B29 gene expression.
Thompson AA; Wood WJ; Gilly MJ; Damore MA; Omori SA; Wall R
Blood; 1996 Jan; 87(2):666-73. PubMed ID: 8555489
[TBL] [Abstract][Full Text] [Related]
13. Assembly and intracellular transport of the human B cell antigen receptor complex.
Brouns GS; de Vries E; Borst J
Int Immunol; 1995 Mar; 7(3):359-68. PubMed ID: 7794818
[TBL] [Abstract][Full Text] [Related]
14. The complete sequence of the human CD79b (Ig beta/B29) gene: identification of a conserved exon/intron organization, immunoglobulin-like regulatory regions, and allelic polymorphism.
Hashimoto S; Chiorazzi N; Gregersen PK
Immunogenetics; 1994; 40(2):145-9. PubMed ID: 7913081
[TBL] [Abstract][Full Text] [Related]
15. The novel variants of mb-1 and B29 transcripts generated by alternative mRNA splicing.
Koyama M; Nakamura T; Higashihara M; Herren B; Kuwata S; Shibata Y; Okumura K; Kurokawa K
Immunol Lett; 1995 Sep; 47(3):151-6. PubMed ID: 8747711
[TBL] [Abstract][Full Text] [Related]
16. Dual requirement for the Ig alpha immunoreceptor tyrosine-based activation motif (ITAM) and a conserved non-Ig alpha ITAM tyrosine in supporting Ig alpha beta-mediated B cell development.
Pike KA; Ratcliffe MJ
J Immunol; 2005 Feb; 174(4):2012-20. PubMed ID: 15699130
[TBL] [Abstract][Full Text] [Related]
17. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of expression of the molecules Igalpha and Igbeta in human pro-B leukemic lines].
Lassoued K; Guglielmi P; Benlagha K
Bull Acad Natl Med; 1997 Oct; 181(7):1465-75. PubMed ID: 9528188
[TBL] [Abstract][Full Text] [Related]
19. Aberrant trafficking of the B cell receptor Ig-alpha beta subunit in a B lymphoma cell line.
Condon C; Hourihane SL; Dang-Lawson M; Escribano J; Matsuuchi L
J Immunol; 2000 Aug; 165(3):1427-37. PubMed ID: 10903747
[TBL] [Abstract][Full Text] [Related]
20. Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
Minegishi Y; Coustan-Smith E; Rapalus L; Ersoy F; Campana D; Conley ME
J Clin Invest; 1999 Oct; 104(8):1115-21. PubMed ID: 10525050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
